Latest News about BMY
Recent news which mentions BMY
Why Shares of Legend Biotech Jumped Wednesday
April 19, 2023
From Motley Fool
Evaxion Biotech Says Personalized Cancer Immunotherapy Meets Primary Endpoint In Melanoma Patients
April 18, 2023
From Benzinga
Merck’s $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology
April 17, 2023
From MarketWatch
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
April 16, 2023
From InvestorPlace
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
April 11, 2023
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
April 11, 2023
From Benzinga
2 Top Stocks to Buy in April and Hold Forever
April 08, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 07, 2023
From Benzinga
2 Ultra-Cheap Dividend Stocks to Buy in April
April 04, 2023
From Motley Fool
Bristol Myers' Flagship Opdivo Shows Long Term Durable Benefits In Lung Cancer Patients
March 30, 2023
Tickers
BMY
From Benzinga
From Benzinga
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
March 28, 2023
From Benzinga
From Motley Fool
From Motley Fool
From Benzinga
Takeda's Highest Dose Psoriasis Candidate Can Potentially Beat Bristol Myers' Approved Drug, Analyst Says
March 20, 2023
From Benzinga
Wall Street Is Bullish on GE HealthCare as It Invests in AI
March 20, 2023
From Motley Fool
4 Top Value Stock ETFs for Long-Term Wealth Building
March 19, 2023
From Motley Fool
2 Top Healthcare Stocks to Buy for the Long Haul
March 17, 2023
From Motley Fool
Buffett loves cash dividends and here’s why you should too – plus 8 stocks with higher yield to get you started.
March 16, 2023
From MarketWatch
From Motley Fool
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
March 13, 2023
From Benzinga
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
From Benzinga
Quant Ratings Updated on 157 Stocks
March 07, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.